title: Prevalence of dermatophytes and yeasts (Candida spp., Malassezia furfur) in HIV patients. A study of former drug addicts.
abstract: The prevalence of dermatophytes and yeasts (Candida spp. and Pityrosporum spp.) was studied in 40 former drug-addicts, all of whom were HIV seropositive but otherwise had no other symptoms (2nd Stage CDC Atlanta, 1987). We considered 7 skin areas for dermatophytes and Pityrosporum spp. (scalp, forehead, nose, back, chest, groin, toe webs) and the mouth for yeasts. Dermatophytes were found in 8 (20%) and tinea pedis was the most common dermatophytosis: Tricophyton rubrum was the fungus most frequently isolated (6 cases or 15%). The HIV+ group showed almost the same rate of dermatophytes colonisation compared to a group of 121 athletes and to the control group. Candida spp. was present in 27 cases (67.5%) but clinical oral lesions were evident only in 5 patients (12.5%). Statistically significant differences were found in the presence of Candida spp. in HIV patients and controls (p less than 0.05). The lipophilic yeast Pityrosporum ovale was evaluated with quantitative and qualitative methods. Quantitative variations were evident between HIV patients and controls. P. ovale was present in 10 cases: 3 (7.5%) of them showed dischromic lesions while in 7 cases (17.5%) no clinical symptoms were evident.
authors.affiliation: Department of Dermatology, University of Pavia, IRCCS Policlinico S. Matteo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Di Silverio
authors.forename: V
authors.initials: V
authors.lastname: Brazzelli
authors.forename: G
authors.initials: G
authors.lastname: Brandozzi
authors.forename: G
authors.initials: G
authors.lastname: Barbarini
authors.forename: A
authors.initials: A
authors.lastname: Maccabruni
authors.forename: S
authors.initials: S
authors.lastname: Sacchi
mesh_terms: D000328:Adult; D003883:Arthrodermataceae / Q000302:isolation & purification*; D002175:Candida / Q000302:isolation & purification; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000382:microbiology*; D006801:Humans; D008290:Malassezia / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D012441:Saccharomyces cerevisiae / Q000302:isolation & purification; D019966:Substance-Related Disorders / Q000150:complications*; D015003:Yeasts / Q000302:isolation & purification*